Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea
· Delayed Price · Currency is KRW 483,000
-8,500 (-1.73%)
Apr 29, 2026, 3:30 PM KST
Hanmi Pharm. Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 6,232,325 | 5,731,457 | 3,556,800 | 4,473,421 | 3,711,167 | 3,373,870 | Upgrade
|
| Market Cap Growth | 118.44% | 61.14% | -20.49% | 20.54% | 10.00% | -23.27% | Upgrade
|
| Enterprise Value | 6,638,311 | 6,103,460 | 4,027,046 | 4,935,354 | 4,226,778 | 4,030,879 | Upgrade
|
| Last Close Price | 491500.00 | 450353.37 | 279478.14 | 349622.87 | 289351.69 | 262307.54 | Upgrade
|
| PE Ratio | 36.78 | 33.80 | 29.32 | 30.59 | 44.83 | 50.34 | Upgrade
|
| Forward PE | 35.37 | 33.64 | 19.54 | 30.57 | 38.01 | 44.63 | Upgrade
|
| PS Ratio | 4.03 | 3.70 | 2.38 | 3.00 | 2.79 | 2.80 | Upgrade
|
| PB Ratio | 4.38 | 4.03 | 2.87 | 4.07 | 3.68 | 3.64 | Upgrade
|
| P/TBV Ratio | 5.20 | 4.78 | 3.42 | 4.92 | 4.51 | 4.47 | Upgrade
|
| P/FCF Ratio | 47.92 | 44.07 | 23.06 | 23.65 | 28.14 | 18.54 | Upgrade
|
| P/OCF Ratio | 36.01 | 33.12 | 18.38 | 20.66 | 22.87 | 16.71 | Upgrade
|
| PEG Ratio | 1.61 | 1.58 | 1.16 | 1.08 | 2.57 | 0.37 | Upgrade
|
| EV/Sales Ratio | 4.29 | 3.94 | 2.69 | 3.31 | 3.17 | 3.35 | Upgrade
|
| EV/EBITDA Ratio | 20.57 | 18.92 | 13.00 | 15.26 | 16.86 | 18.79 | Upgrade
|
| EV/EBIT Ratio | 29.65 | 27.26 | 18.95 | 21.95 | 27.47 | 32.14 | Upgrade
|
| EV/FCF Ratio | 51.05 | 46.93 | 26.11 | 26.09 | 32.05 | 22.15 | Upgrade
|
| Debt / Equity Ratio | 0.31 | 0.31 | 0.40 | 0.52 | 0.67 | 0.82 | Upgrade
|
| Debt / EBITDA Ratio | 1.35 | 1.35 | 1.60 | 1.77 | 2.71 | 3.53 | Upgrade
|
| Debt / FCF Ratio | 3.34 | 3.34 | 3.22 | 3.03 | 5.14 | 4.16 | Upgrade
|
| Net Debt / Equity Ratio | 0.16 | 0.16 | 0.25 | 0.29 | 0.44 | 0.59 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.72 | 0.72 | 0.98 | 0.98 | 1.76 | 2.54 | Upgrade
|
| Net Debt / FCF Ratio | 1.79 | 1.79 | 1.97 | 1.68 | 3.35 | 2.99 | Upgrade
|
| Asset Turnover | 0.74 | 0.74 | 0.76 | 0.78 | 0.69 | 0.63 | Upgrade
|
| Inventory Turnover | 2.07 | 2.07 | 2.30 | 2.38 | 2.37 | 2.04 | Upgrade
|
| Quick Ratio | 0.90 | 0.90 | 0.63 | 0.61 | 0.62 | 0.67 | Upgrade
|
| Current Ratio | 1.48 | 1.48 | 1.09 | 1.04 | 1.03 | 1.08 | Upgrade
|
| Return on Equity (ROE) | 14.05% | 14.05% | 12.00% | 15.68% | 10.48% | 9.26% | Upgrade
|
| Return on Assets (ROA) | 6.73% | 6.73% | 6.78% | 7.35% | 4.98% | 4.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.22% | 12.26% | 11.77% | 13.37% | 8.83% | 6.66% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.60% | 14.60% | 15.90% | 18.80% | 12.30% | 9.70% | Upgrade
|
| Earnings Yield | 2.72% | 2.96% | 3.41% | 3.27% | 2.23% | 1.99% | Upgrade
|
| FCF Yield | 2.09% | 2.27% | 4.34% | 4.23% | 3.55% | 5.39% | Upgrade
|
| Payout Ratio | 18.20% | 18.20% | 10.35% | 12.31% | 7.24% | 8.77% | Upgrade
|
| Buyback Yield / Dilution | -0.07% | -0.07% | 0.08% | 0.09% | 0.12% | 0.11% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.